New Study Hopes to Use Pancreatic Cancer Pill Earlier in Treatment

Researchers have found that combining daraxonrasib with chemotherapy drugs gemcitabine and nab-paclitaxel significantly reduced tumours in 60.7% of patients and halted growth in 90% of patients with metastatic pancreatic cancer. The study suggests the pill could be used earlier in treatment, alongside chemotherapy, offering new hope for patients. The findings were presented at the EORTC-NCI-AACR Symposium in Barcelona.








